Lead researcher: Crohn’s & Colitis UK
Lead researcher: Crohn’s & Colitis UK
Our Life in Lockdown survey ran during June and July - an incredible 7,666 people with Crohn’s and Colitis took part to help us understand the impact of the coronavirus pandemic. Here are some of the key results:
For more information on these results, visit our news item.
The CLARITY trial is looking at the impact of infliximab and vedolizumab on COVID-19 infection, vaccination and immune response in people with Crohn’s or Colitis.
Researchers wanted to find out how people with chronic pain (i.e., pelvic, stomach, back, neck, shoulder, nerve pain etc.) were affected by the pandemic.
Early in the pandemic, a research team in Australia conducted a global study to see what different groups of people wanted to see measured in COVID-19 clinical trials.
We know it can be difficult to live with, or support someone living with these conditions. But you’re not alone. We provide up-to-date, evidence-based information and can support you to live well with Crohn’s or Colitis.
Our helpline team can help by:
Providing information about Crohn’s and Colitis.
Listening and talking through your situation.
Helping you to find support from others in the Crohn’s and Colitis community.
Providing details of other specialist organisations.
Please be aware we’re not medically or legally trained. We cannot provide detailed financial or benefits advice or specialist emotional support.
Please contact us via telephone, email or LiveChat - 9am to 5pm, Monday to Friday (except English bank holidays).
If you need specific medical advice about your condition, your GP or IBD team will be best placed to help.
Would you like to save the changes made to this page?
Your details were successfully saved.